2nd Quarter - Report — SOCIETY OF NUCLEAR MEDICINE AND MOLECUL… for SOCIETY OF NUCLEAR MEDICINE AND MOLECUL… (2013)

Firm

SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Client

SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Income

—

Expenses

$110,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 1146 and S. 642) Implementation of the Affordable Care Act generally.

Lobbyist	Covered position, as disclosed
SUSAN KATHLEEN BUNNING	—
JESSE SCHOOLNIK	—

Contacted: Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Energy, Dept of; Nuclear Regulatory Commission (NRC); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: S. 642 (113th), H.R. 1146 (113th)

Budget/Appropriations BUD

FY '14 (S. 1245, and House bill) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III) FY'14 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.

Lobbyist	Covered position, as disclosed
SUSAN KATHLEEN BUNNING	—
JESSE SCHOOLNIK	—

Contacted: Natl Institutes of Health (NIH); Energy, Dept of; Nuclear Regulatory Commission (NRC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: S. 1245 (113th)

Energy/Nuclear ENG

Domestic isotope supply issues, including S. 99 (American Medical Isotopes Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.

Lobbyist	Covered position, as disclosed
SUSAN KATHLEEN BUNNING	—
JESSE SCHOOLNIK	—

Contacted: Energy, Dept of; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Nuclear Regulatory Commission (NRC); SENATE; Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 99 (113th)

Pharmacy PHA

Pharmacy compounding of radiopharmaceuticals; S. 959, Pharmaceutical Quality, Security, and Accountability Act), nuclear medicine provisions.

Lobbyist	Covered position, as disclosed
SUSAN KATHLEEN BUNNING	—
JESSE SCHOOLNIK	—

Contacted: HOUSE OF REPRESENTATIVES; Energy, Dept of; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Nuclear Regulatory Commission (NRC); SENATE

Bills named: S. 959 (113th)

Medicare/Medicaid MMM

Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Sustainable growth rate (SGR) physician payment reform generally.

Lobbyist	Covered position, as disclosed
SUSAN KATHLEEN BUNNING	—
JESSE SCHOOLNIK	—

Contacted: Natl Institutes of Health (NIH); SENATE; Food & Drug Administration (FDA); Nuclear Regulatory Commission (NRC); Energy, Dept of; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.